Levagen 10 Mg (Lenvatinib)

Description

About Levagen 10 Mg

Each capsule of Levagen 10mg contains Lenvatinib Mesylate INN equivalent to Lenvatinib 10mg. Lenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors. General Pharmaceuticals LTD is the manufacturer of Levagen 10mg. Each box of Levagen 10mg contains 30 capsules.

Dosage

Recommended dosage for Levagen 10mg is one tablet orally twice daily, with or without food until disease progression or unacceptable toxicity. Whole capsule should be swallowed with water and the capsule should not be chewed or crushed. Or, as directed by the registered physician.

Side Effects

• Diarrhoea
• Hypertension
• Cardiac Dysfunction
• Hepatotoxicity
• Arterial Thromboembolic Events
• Proteinuria
• Hypocalcemia
• Renal Failure or Impairment

Storage

Levagen 10 mg should be stored below 30°C in a dry and clean place, away from sunlight and out of the reach of children.